Light-induced cytotoxicity after aminolevulinic acid treatment is mediated by heme and not by iron

Journal of Photochemistry and Photobiology B: Biology

Volumn 99, Issue 1, 2010, Pages 36-43

  Breusing, Nicolle ^a   Grimm, Stefanie ^a   Mvondo, Dagmar ^a   Flaccus, Andrea ^a   Biesalski, Hans Konrad ^a   Grune, Tilman ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Free radicals; Heme oxygenase 1; Oxidative stress; Photodynamic therapy; Protein oxidation

Indexed keywords

AMINOLEVULINIC ACID; DEFEROXAMINE; FERRITIN; HEME; HEME OXYGENASE 1; HEMIN; IRON; PROTOPORPHYRIN ZINC;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; DEFEROXAMINE; HEME; HEME OXYGENASE-1; HUMANS; IRON; IRON CHELATING AGENTS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES;

EID: 77952242317     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2010.01.012     Document Type: Article

References (25)

1. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br. J. Dermatol. 2007, 156:793-801.
2. McBride G. Studies expand potential uses of photodynamic therapy. J. Natl. Cancer Inst. 2002, 94:1740-1742.
3. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90:889-905.
4. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1:279-293.
5. Nowis D., Makowski M., Stokłosa T., Legat M., Issat T., Gołab J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim. Pol. 2005, 52:339-352.
6. Lang K., Bolsen K., Stahl W., Ruzicka T., Sies H., Lehmann P., Fritsch C. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J. Photochem. Photobiol. B. 2001, 65:29-34.
7. Nowis D., Legat M., Grzela T., Niderla J., Wilczek E., Wilczynski G.M., Głodkowska E., Mrówka P., Issat T., Dulak J., Józkowicz A., Waś H., Adamek M., Wrzosek A., Nazarewski S., Makowski M., Stokłosa T., Jakóbisiak M., Gołab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006, 25:3365-3374.
8. Gomer C.J., Ferrario A., Rucker N., Wong S., Lee A.S. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res. 1991, 51:6574-6579.
9. Gomer C.J., Luna M., Ferrario A., Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem. Photobiol. 1991, 53:275-279.
10. Luna M.C., Wong S., Gomer C.J. Photodynamic therapy mediated induction of early response genes. Cancer Res. 1994, 54:1374-1380.
11. Bolsen K., Lang K., Verwohlt B., Fritsch C., Goerz G. In vitro induction of porphyrin biosynthesis in various human cells after incubation with 5-aminolevulinic acid. Arch. Dermatol. Res. 1996, 288:320A.
12. Fritsch C., Batz J., Bolsen K., Schulte K.W., Zumdick M., Ruzicka T., Goerz G. Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem. Photobiol. 1997, 66:114-118.
13. Eberle J., Garbe C., Wang N., Orfanos C.E. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigm. Cell Res. 1995, 8:307-313.
14. Berg K., Anholt H., Bech O., Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br. J. Cancer 1996, 74:688-697.
15. Lin F., Girotti A.W. Hyperresistance of leukemia cells to photodynamic inactivation after long-term exposure to hemin. Cancer Res. 1996, 56:4636-4643.
16. Doré S., Takahashi M., Ferris C.D., Zakhary R., Hester L.D., Guastella D., Snyder S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. USA 1999, 96:2445-2450.
17. Buss H., Chan T.P., Sluis K.B., Domigan N.M., Winterbourn C.C. Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biol. Med. 1997, 23:361-366.
18. Voss P., Horakova L., Jakstadt M., Kiekebusch D., Grune T. Ferritin oxidation and proteasomal degradation: protection by antioxidants. Free Radical Res. 2006, 40:673-683.
19. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B 1997, 39:1-18.
20. Frank J., Lornejad-Schäfer M.R., Schöffl H., Flaccus A., Lambert C., Biesalski H.K. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int. J. Oncol. 2007, 31:1539-1545.
21. Hanania J., Malik Z. The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett. 1992, 65:127-131.
22. Moan J., Rimington C., Evensen J.F., Western A. Binding of porphyrins to serum proteins. Adv. Exp. Med. Biol. 1985, 193:193-205.
23. Asad S.F., Singh S., Ahmad A., Khan N.U., Hadi S.M. Prooxidant and antioxidant activities of bilirubin and its metabolic precursor biliverdin: a structure-activity study. Chem. Biol. Interact. 2001, 137:59-74.
24. Balla J., Jacob H.S., Balla G., Nath K., Vercellotti G.M. Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans. Assoc. Am. Physicians 1992, 105:1-6.
25. Doulias P.T., Christoforidis S., Brunk U.T., Galaris D. Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. Free Radical Biol. Med. 2003, 35:719-728.